Cargando…
A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (−) prostate cancer specific therapy
BACKGROUND: The selectively accumulate in tumor site and completely release drug within cancer cells great limit the therapeutic effect of nano-drug delivery system. Moreover, absence of appropriate biomarker is one of the major challenges for prostate specific membrane antigen negative (PSMA (−)) p...
Autores principales: | Wang, Yifan, Zhang, Yanqiu, Ru, Zhengxing, Song, Wei, Chen, Lin, Ma, Hao, Sun, Lizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709549/ https://www.ncbi.nlm.nih.gov/pubmed/31451114 http://dx.doi.org/10.1186/s12951-019-0521-z |
Ejemplares similares
-
A pH/ROS Cascade‐Responsive Charge‐Reversal Nanosystem with Self‐Amplified Drug Release for Synergistic Oxidation‐Chemotherapy
por: Dai, Liangliang, et al.
Publicado: (2018) -
Multiple stimuli-responsive nanosystem for potent, ROS-amplifying, chemo-sonodynamic antitumor therapy
por: Tang, JunJie, et al.
Publicado: (2021) -
A co-delivery system based on chlorin e6-loaded ROS-sensitive polymeric prodrug with self-amplified drug release to enhance the efficacy of combination therapy for breast tumor cells
por: Wang, Cui, et al.
Publicado: (2023) -
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
por: Boinapally, Srikanth, et al.
Publicado: (2021) -
Stimuli-Responsive Polymeric Nanosystem for Colon Specific Drug Delivery
por: Joseph, Sharon Kunnath, et al.
Publicado: (2020)